1. A clinical and echocardiographic score to differentiate pulmonary hypertension due to heart failure with preserved ejection fraction from idiopathic pulmonary hypertension: the PH-HFPEF score. (3rd October 2022) Authors: Dardi, F; Ballerini, A; Guarino, D; Donato, F; Bertozzi, R; Martini, G; Magnani, I; Manes, A; Palazzini, M; Galie', N Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Additional role of echocardiogram in pulmonary arterial hypertension risk stratification according to current ESC/ERS guidelines. (25th November 2020) Authors: Rotunno, M; Dardi, F; De Lorenzis, A; Palazzini, M; Zuffa, E; Pasca, F; Guarino, D; Magnani, I; Ballerini, A; Manes, A; Galie, N Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Echocardiographic predictors of low risk haemodynamic parameters in patients with pulmonary arterial hypertension. (14th October 2021) Authors: Rotunno, M; Dardi, F; Palazzini, M; Guarino, D; Zuffa, E; Magnani, I; De Lorenzis, A; Ballerini, A; Manes, A; Galie, N Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Intratumor Heterogeneity and Its Impact on Drug Distribution and Sensitivity. Issue 2 (14th May 2014) Authors: Fuso Nerini, I; Morosi, L; Zucchetti, M; Ballerini, A; Giavazzi, R; D'Incalci, M Journal: Clinical pharmacology & therapeutics Issue: Volume 96:Issue 2(2014) Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognostic role of comorbidities in patients with pulmonary arterial hypertension. (25th November 2020) Authors: De Lorenzis, A; Dardi, F; Palazzini, M; Zuffa, E; Pasca, F; Guarino, D; Magnani, I; Rotunno, M; Ballerini, A; Manes, A; Galie, N Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Role of cardiac magnetic resonance in stratifying the prognosis of patients with pulmonary arterial hypertension. (14th October 2021) Authors: De Lorenzis, A; Dardi, F; Guarino, D; Palazzini, M; Magnani, I; Zuffa, E; Ballerini, A; Rotunno, M; Manes, A; Galie, N Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Short term effect of Selexipag in comparison to parenteral prostacyclin analogues in pulmonary arterial hypertension patients started on double-combination therapy with ERA and PDE-5 inhibitors. (25th November 2020) Authors: Dardi, F; Zuffa, E; Palazzini, M; Pasca, F; De Lorenzis, A; Guarino, D; Magnani, I; Ballerini, A; Rotunno, M; Manes, A; Galie, N Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Survival of patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension listed for lung transplantation. (14th October 2021) Authors: Magnani, I; Dardi, F; Palazzini, M; Zuffa, E; Guarino, D; Daddi, N; Dolci, G; Antonacci, F; Solli, P; Paganelli, G M; De Lorenzis, A; Rotunno, M; Ballerini, A; Manes, A; Galie, N Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗